IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
(2003; 82 pages) Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentAbbreviations and acronyms
Afficher le documentIntroduction
Afficher le document1. General articles
Ouvrir ce répertoire et afficher son contenu2. Country studies by region
Ouvrir ce répertoire et afficher son contenu3. TRIPS, drugs and human rights
Fermer ce répertoire4. Electronic information
Afficher le document4.1 Some useful web sites
Afficher le document4.2 Interesting discussion groups
Afficher le documentOther documents in the EDM Health Economics and Drugs Series
Afficher le documentBack cover
 

4.2 Interesting discussion groups

The issue of the impact of international trade agreements on access to drugs and the pharmaceutical sector is increasingly debated through two electronic discussion groups.

http://www.essentialdrugs.org

E-drug is an electronic conference on essential drugs. E-drug is used by professionals in this field to obtain and discuss current information on essential drugs, including international and national policies, and standard treatment guidelines. Discussions are held in English, French and Spanish.

http://www.hivnet.ch

Treatment-Access is an electronic discussion forum created and managed by the Fondation du Présent, a not-for-profit organization which brings together a multisectoral community of more than 12 000 members - half of them in developing countries - to raise and jointly resolve AIDS-related issues through email discussion.

http://lists.essential.org/mailman/listinfo/ip-health

Ip-health is an electronic newsletter devoted to the relationship and links between intellectual property and health care. The pharm-policy list is no longer in use and has been integrated into this one as their subjects were overlapping. It is one of the most complete and useful lists to follow the evolution of TRIPS.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013